| |
| |
|
| Insider
Information: |
Manning Anthony M. |
| Relationship: |
Chief Scientific Officer |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
36,693 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$73,386 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
36,693 |
|
|
| Total
Value |
$73,386 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Palatin Technologies Inc |
PTN |
|
2023-06-20 |
36,693 |
2017-09-07 |
0 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
Chief Scientific Officer |
2020-10-01 |
0 |
2018-11-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTN |
Palatin Technologies Inc |
|
• • – |
2017-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
54,000 |
54,000 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
|
• • – |
2017-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
|
• • – |
2018-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
30,333 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2018-11-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
63,156 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2018-11-08 |
4 |
AS |
$14.09 |
$3,227 |
D/D |
(229) |
62,927 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2018-11-12 |
4 |
AS |
$13.15 |
$1,486 |
D/D |
(113) |
62,814 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
63,564 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-02-08 |
4 |
AS |
$11.52 |
$3,041 |
D/D |
(264) |
63,300 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
88,167 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-02-12 |
4 |
AS |
$12.77 |
$1,698 |
D/D |
(133) |
63,167 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-02-13 |
4 |
AS |
$12.70 |
$98,006 |
D/D |
(7,717) |
80,450 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-02-14 |
4 |
AS |
$13.10 |
$58,282 |
D/D |
(4,449) |
76,001 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-04-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,000) |
46,001 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
46,751 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-05-08 |
4 |
AS |
$13.68 |
$3,064 |
D/D |
(224) |
46,527 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-05-10 |
4 |
AS |
$14.00 |
$1,596 |
D/D |
(114) |
46,413 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-06-20 |
4 |
AS |
$13.00 |
$512,629 |
D/D |
(39,433) |
6,980 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
|
• • – |
2019-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
97,333 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-08-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
7,730 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-08-08 |
4 |
AS |
$11.82 |
$2,612 |
D/D |
(221) |
7,509 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-08-08 |
4/A |
AS |
$11.67 |
$2,637 |
D/D |
(226) |
7,504 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-08-12 |
4 |
AS |
$11.64 |
$1,327 |
D/D |
(114) |
7,390 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-10-14 |
4 |
AS |
$13.55 |
$10,664 |
D/D |
(787) |
6,603 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-10-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,000 |
20,603 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-10-18 |
4 |
AS |
$13.83 |
$88,028 |
D/D |
(6,365) |
14,238 |
0 |
- |
|
68 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
